← Leaderboards
Morali Sharma
Baylor College Of Medicine
$13,547
Attributed
$13,547
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$13,547 · 4
By mechanism
M01$13,547 · 4
Top collaborators
No co-investigators on record.
Most similar at Baylor College Of Medicine
Same institution · by research overlap
- Lawrence Chan$23,286,228
- Ashok Balasubramanyam$21,769,207
- Bert W O'Malley$52,747,816
- Hong Wang$22,354,650
- Zheng Sun$12,331,610
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectLongitudinal Human StudyAdult Human (21+)Hormone TherapyHuman Therapy EvaluationSomatotropinLipid MetabolismGlucose MetabolismPituitary DwarfismProtein MetabolismDrug Screening /EvaluationCarbohydrate MetabolismDrug Adverse EffectGlucose Tolerance TestHiv InfectionsAids TherapyStable IsotopeIatrogenic DiseaseMass SpectrometryMedical ComplicationMetabolism DisorderPathologic ProcessPatient Oriented Research
Grant awards (7)
EFFECT OF GROWTH HORMONE REPLACEMENT ON METABOLISM IN GH DEFICIENT PATIENTS$3,324
M01 · FY2005 · RR
Growth Hormone Replacement on Metabolism in GH Deficient$9,797
M01 · FY2004 · RR
Metabolic Studies in Growth Hormone Deficient Patients$426
M01 · FY2004 · RR
PATHOGENESIS OF HIV PROTEASE INHIBITOR METABOLIC SYNDROME$0
M01 · FY2001 · RR
METABOLIC STUDIES IN GROWTH HORMONE DEFICIENT PATIENTS$0
M01 · FY2001 · RR
METABOLIC STUDIES IN GROWTH HORMONE DEFICIENT PATIENTS$0
M01 · FY2000 · RR
PATHOGENESIS OF HIV PROTEASE INHIBITOR METABOLIC SYNDROME$0
M01 · FY2000 · RR